Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.
Pluronic block copolymers have been previously reported to increase the delivery of agents to the brain [Kabanov et al. (1992) J. Controlled Release 22, 141-158]. In the present study, primary cultured bovine brain microvessel endothelial cells (BBMEC) were used as an in vitro model of the blood-brain barrier to examine the membrane interactions of Pluronic P85 (P85) and potential mechanisms for drug absorption. At concentrations below the critical micelle concentration (cmc), P85 enhanced the accumulation of the fluorescent probe rhodamine 123 (R123) in BBMEC through inhibition of P-glycoprotein (P-gp)-mediated drug efflux. The effects of P85 on the cellular accumulation of R123 were also observed in KBv cells (P-gp positive) but not in human umbilical vein endothelial cells (P-gp negative). In contrast to the effects with P85 below the cmc, the enhanced absorption of R123 observed with Pluronic micelles was transient and not dependent on P-gp. A transient increase in R123 accumulation was observed in both P-gp positive cells (brain microvessel endothelial cells and KBv) and P-gp negative cells (human umbilical vein endothelial cells). Therefore, it appears that P85 affects the absorption of drugs in brain microvessel endothelial cells through (1) inhibition of the P-gp-mediated drug efflux at low concentrations of the copolymer and (2) increased vesicular transport at higher concentrations of the copolymer. Furthermore, both interactions of P85 with the brain endothelial cells appear to be energy-dependent as demonstrated by the inhibitory effects of the metabolic inhibitor 2-deoxyglucose.
Miller
D W
DW
Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha 68198, USA.
Batrakova
E V
EV
Waltner
T O
TO
Alakhov VYu
Kabanov
A V
AV
D000042:Absorption; D000818:Animals; D000963:Antimetabolites / Q000008:administration & dosage / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002196:Capillaries / Q000187:drug effects; D002417:Cattle; D002478:Cells, Cultured; D002560:Cerebrovascular Circulation; D003470:Culture Media; D003847:Deoxyglucose / Q000008:administration & dosage / Q000494:pharmacology; D004337:Drug Carriers; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D004734:Energy Metabolism; D005456:Fluorescent Dyes; D006801:Humans; D008823:Micelles; D008856:Microscopy, Fluorescence; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011060:Poloxalene / Q000494:pharmacology*
D000963:Antimetabolites; D003470:Culture Media; D004337:Drug Carriers; D005456:Fluorescent Dyes; D008823:Micelles; D004364:Pharmaceutical Preparations; D011060:Poloxalene; D003847:Deoxyglucose